| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
JMDC Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥19.10 |
| 52 Week High | JP¥36.60 |
| 52 Week Low | JP¥14.80 |
| Beta | 0.45 |
| 11 Month Change | 17.90% |
| 3 Month Change | -13.18% |
| 1 Year Change | -52.72% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -47.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6JM | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -2.1% | 1.0% | 0.09% |
| 1Y | -52.7% | -26.2% | 3.1% |
Return vs Industry: 6JM underperformed the German Healthcare Services industry which returned -25.1% over the past year.
Return vs Market: 6JM underperformed the German Market which returned 2.9% over the past year.
Price Volatility
| 6JM volatility | |
|---|---|
| 6JM Average Weekly Movement | 6.6% |
| Healthcare Services Industry Average Movement | 3.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 6JM has not had significant price volatility in the past 3 months.
Volatility Over Time: 6JM's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,484 | Ryo Noguchi | www.jmdc.co.jp |
JMDC Inc. provides medical statistics data services in Japan. The company offers medical field big data services; life insurance field big data services; support services for health insurance associations and local government health services; health data platform; and medical institution support services. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, research institutions, etc. JMDC Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan.
JMDC Inc. Fundamentals Summary
| 6JM fundamental statistics | |
|---|---|
| Market cap | €1.27b |
| Earnings (TTM) | €26.99m |
| Revenue (TTM) | €189.73m |
47.0x
P/E Ratio6.7x
P/S RatioIs 6JM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6JM income statement (TTM) | |
|---|---|
| Revenue | JP¥32.38b |
| Cost of Revenue | JP¥13.13b |
| Gross Profit | JP¥19.25b |
| Other Expenses | JP¥14.65b |
| Earnings | JP¥4.61b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 02, 2024
| Earnings per share (EPS) | 70.52 |
| Gross Margin | 59.46% |
| Net Profit Margin | 14.23% |
| Debt/Equity Ratio | 40.9% |
How did 6JM perform over the long term?
See historical performance and comparison